Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy

G. Széplaki, Emin Evren Özcan, István Osztheimer, Tamás Tahin, B. Merkely, L. Gellér

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Brugada syndrome is associated with a high risk of sudden cardiac death. Currently, the cornerstone of therapy is implantation of an implantable cardioverter defibrillator (ICD). Recently, a novel approach to preventively ablate the substrate located in the anterior epicardial region of the right ventricular outflow tract showed promising results by reducing the number of ventricular fibrillation episodes in patients with ICD. Here we report on a patient with Brugada syndrome who refused ICD therapy in whom a successful epicardial right ventricular outflow tract substrate ablation was performed. In some special cases, ablation therapy might be considered as the sole therapeutic option for these patients.

Original languageEnglish
Pages (from-to)1249e9-1249e11
JournalCanadian Journal of Cardiology
Volume30
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Brugada Syndrome
Implantable Defibrillators
Sudden Cardiac Death
Ventricular Fibrillation
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy. / Széplaki, G.; Özcan, Emin Evren; Osztheimer, István; Tahin, Tamás; Merkely, B.; Gellér, L.

In: Canadian Journal of Cardiology, Vol. 30, No. 10, 01.10.2014, p. 1249e9-1249e11.

Research output: Contribution to journalArticle

@article{cd43f702478940fcb8981572fbe4636d,
title = "Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy",
abstract = "Brugada syndrome is associated with a high risk of sudden cardiac death. Currently, the cornerstone of therapy is implantation of an implantable cardioverter defibrillator (ICD). Recently, a novel approach to preventively ablate the substrate located in the anterior epicardial region of the right ventricular outflow tract showed promising results by reducing the number of ventricular fibrillation episodes in patients with ICD. Here we report on a patient with Brugada syndrome who refused ICD therapy in whom a successful epicardial right ventricular outflow tract substrate ablation was performed. In some special cases, ablation therapy might be considered as the sole therapeutic option for these patients.",
author = "G. Sz{\'e}plaki and {\"O}zcan, {Emin Evren} and Istv{\'a}n Osztheimer and Tam{\'a}s Tahin and B. Merkely and L. Gell{\'e}r",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.cjca.2014.05.019",
language = "English",
volume = "30",
pages = "1249e9--1249e11",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "10",

}

TY - JOUR

T1 - Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy

AU - Széplaki, G.

AU - Özcan, Emin Evren

AU - Osztheimer, István

AU - Tahin, Tamás

AU - Merkely, B.

AU - Gellér, L.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Brugada syndrome is associated with a high risk of sudden cardiac death. Currently, the cornerstone of therapy is implantation of an implantable cardioverter defibrillator (ICD). Recently, a novel approach to preventively ablate the substrate located in the anterior epicardial region of the right ventricular outflow tract showed promising results by reducing the number of ventricular fibrillation episodes in patients with ICD. Here we report on a patient with Brugada syndrome who refused ICD therapy in whom a successful epicardial right ventricular outflow tract substrate ablation was performed. In some special cases, ablation therapy might be considered as the sole therapeutic option for these patients.

AB - Brugada syndrome is associated with a high risk of sudden cardiac death. Currently, the cornerstone of therapy is implantation of an implantable cardioverter defibrillator (ICD). Recently, a novel approach to preventively ablate the substrate located in the anterior epicardial region of the right ventricular outflow tract showed promising results by reducing the number of ventricular fibrillation episodes in patients with ICD. Here we report on a patient with Brugada syndrome who refused ICD therapy in whom a successful epicardial right ventricular outflow tract substrate ablation was performed. In some special cases, ablation therapy might be considered as the sole therapeutic option for these patients.

UR - http://www.scopus.com/inward/record.url?scp=84908009620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908009620&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2014.05.019

DO - 10.1016/j.cjca.2014.05.019

M3 - Article

C2 - 25262866

AN - SCOPUS:84908009620

VL - 30

SP - 1249e9-1249e11

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 10

ER -